Diagnòstic genètic preimplantacional en estadis embrionaris tardans

Authors

  • Mònica Parriego
  • Anna Veiga i Lluch
  • Francesca Vidal

Abstract

The incorporation of blastocyst biopsy into clinical practice can be considered as a valid alternative when performing PGD. The fact that it makes more material available for analysis is of particular value in those cases where the aim is to diagnose monogenic diseases. The availability of a greater number of cells opens the possibility of performing multiple diagdiagnoses in parallel on the same embryo; these could be used to detect multigenic diseases or for the combined diagnosis of different disorders through diagnostic approaches based on both FISH and PCR. Embryos transferred at the blastocyst stage are subjected to a dual selection process (genetic and through culture) and this is reflected in their greater implantation potential, thus enabling a lower number of embryos to be transferred, which in turn reduces the risk of multiple pregnancy. Although the clinical application of blastocyst biopsy for PGD remains a limited and recent development, the good results in terms of implantation and pregnancy rates obtained so far, as well as the diagnostic possibilities it opens up, suggest that this technique can become more widely used in the early future.

Downloads

Download data is not yet available.

Published

2009-04-27